Drug Search Results
More Filters [+]

Loxoprofen

Alternative Names: loxoprofen
Latest Update: 2024-07-19
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: COX1 Inhibitor,Prostaglandin Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Transdermal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | China | Colombia | Dominican Republic | Egypt | India | Japan | Jordan | Korea | Lebanon | Malaysia | Mexico | Pakistan | Philippines | Saudi Arabia | Taiwan | Turkey | United Arab Emirates | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: LEAD CHEMICAL COMPANY, LIMITED
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Loxoprofen

Countries in Clinic:

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Acute Pain

Phase 1: Myalgia|Osteoarthritis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

JY-BE-LSLF-2024-042

P1

Not yet recruiting

Myalgia|Osteoarthritis

2024-08-01

2020-003543-29

P3

Active, not recruiting

Acute Pain

2022-05-07

Recent News Events